Chor Sing Tan is a seasoned professional in the biopharma industry, currently serving as the Global Strategic Account & Thought Leader at Repligen Corporation since January 2024. Previously, Chor Sing held the position of Principal Consultant at Vantage Pt LLC, providing strategic guidance on bioprocessing technology and business model innovation. With a robust background at Cytiva and GE Healthcare, including roles as Strategy Manager and Global Single Use Technology Application Leader, Chor Sing has focused on sustainability and growth within life sciences. Educational qualifications include a PhD in Chemical and Biomolecular Engineering from the University of Melbourne and additional credentials from the Massachusetts Institute of Technology and APMG International.
This person is not in any teams
This person is not in any offices